Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD : the ERICA study
暂无分享,去创建一个
D. Lomas | B. Miller | W. MacNee | I. Wilkinson | P. Calverley | C. McEniery | C. Bolton | Ruth | J. Fuld | D. Mohan | M. Fisk | J. Cheriyan | J. Forman | N. Gale | M. Allinder | Mellone N. Marchong | S. Nagarajan | R. Cockcroft | John | Tal-Singer
[1] M. Polkey,et al. Evaluating the Role of Inflammation in Chronic Airways Disease: The ERICA Study , 2014, COPD.
[2] J. Pépin,et al. Arterial stiffness in COPD. , 2014, Chest.
[3] E. Wouters,et al. Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation , 2013, European Respiratory Journal.
[4] Martijn A Spruit,et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[5] B. Celli,et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[6] M. Puhan,et al. Characteristics of Dutch and Swiss primary care COPD patients – baseline data of the ICE COLD ERIC study , 2011, Clinical epidemiology.
[7] M. Polkey,et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.
[8] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.